# Fabry Patient's Experience Of PegunigaLsidasE Alfa Monthly Infusion

> **NCT05186324** · — · COMPLETED · sponsor: **Chiesi Farmaceutici S.p.A.** · enrollment: 23 (actual)

## Conditions studied

- Fabry Disease

## Interventions

- **OTHER:** Interview

## Key facts

- **NCT ID:** NCT05186324
- **Lead sponsor:** Chiesi Farmaceutici S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-26
- **Primary completion:** 2022-08-31
- **Final completion:** 2022-08-31
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2023-03-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05186324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05186324, "Fabry Patient's Experience Of PegunigaLsidasE Alfa Monthly Infusion". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05186324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*